Doxazosin Mesilate

This article explores the use of Doxazosin Mesilate, also known as Doxazosin, in various clinical trials. Doxazosin is a medication that belongs to a class of drugs called alpha-1 adrenergic blockers. It has been studied for its potential benefits in treating conditions such as benign prostatic hyperplasia (BPH), cocaine dependence, post-traumatic stress disorder (PTSD), and smoking cessation. The trials discussed here aim to evaluate the safety, efficacy, and potential new applications of Doxazosin in improving patient outcomes across different medical conditions.

Table of Contents

What is Doxazosin Mesylate?

Doxazosin mesylate is a medication that belongs to a class of drugs called alpha-1 adrenergic blockers. It is commonly known by its brand names Cardura, Cardura XL, or Alfadil XL[1]. Doxazosin works by relaxing blood vessels and improving blood flow in certain parts of the body[2].

What Conditions Does Doxazosin Treat?

Doxazosin is primarily used to treat the following conditions:

  • Benign Prostatic Hyperplasia (BPH): This is a non-cancerous enlargement of the prostate gland that can cause urinary problems in men[1].
  • Hypertension: Doxazosin is FDA-approved for treating high blood pressure[3].

Additionally, researchers are exploring its potential use in treating other conditions, including:

  • Post-Traumatic Stress Disorder (PTSD): Some studies are investigating whether doxazosin can help reduce nightmares and improve sleep quality in people with PTSD[4][3].
  • Cocaine Dependence: Researchers are studying if doxazosin can help reduce cocaine cravings and use in people with cocaine addiction[5][6].

How Does Doxazosin Work?

Doxazosin works by blocking alpha-1 adrenergic receptors in the body. These receptors are found in various tissues, including blood vessels, the prostate, and the brain. By blocking these receptors, doxazosin can:

  • Relax blood vessels, which helps lower blood pressure[3].
  • Relax muscles in the prostate and bladder, which can improve urinary symptoms in men with BPH[1].
  • Potentially affect brain chemistry in ways that might help with conditions like PTSD and addiction, though this is still being researched[4][5].

Dosage and Administration

The dosage of doxazosin can vary depending on the condition being treated and the individual patient. Here are some general guidelines based on the clinical trials:

  • For BPH: Doses typically range from 4mg to 8mg once daily[1].
  • For research on PTSD: Studies have used doses up to 16mg per day[4][3].
  • For research on cocaine dependence: Studies have used doses up to 8mg per day[5][6].

Doxazosin is usually started at a low dose and gradually increased to minimize side effects. It’s typically taken once daily, often at bedtime[3].

Potential Side Effects

Like all medications, doxazosin can cause side effects. Some potential side effects include:

  • Dizziness or lightheadedness: This is especially common when first starting the medication or increasing the dose[3].
  • Postural hypotension: This is a sudden drop in blood pressure when standing up, which can cause dizziness or fainting[1].
  • Fatigue or weakness
  • Headache
  • Swelling in the feet or ankles

In some studies, researchers also monitored for potential effects on sexual function in both men and women[3].

Ongoing Research and Potential New Uses

Researchers are actively studying doxazosin for several new potential uses:

  • PTSD treatment: Studies are investigating whether doxazosin can help reduce nightmares, improve sleep quality, and alleviate other PTSD symptoms[4][3][7].
  • Cocaine addiction treatment: Researchers are exploring if doxazosin can help reduce cocaine cravings and use in people with cocaine dependence[5][6][2].
  • Smoking cessation: One study is examining whether doxazosin can help reduce stress-induced smoking and improve outcomes in people trying to quit smoking[8].

These studies are still in progress, and more research is needed before doxazosin can be recommended for these conditions. Patients should always consult with their healthcare provider about the most appropriate treatments for their specific situation.

Aspect Details
Primary Conditions Studied Benign Prostatic Hyperplasia (BPH), Cocaine Dependence, Post-Traumatic Stress Disorder (PTSD), Smoking Cessation
Dosage Range 1-10 mg daily, with some trials using up to 16 mg
Administration Oral, typically taken once daily
Trial Durations 8 weeks to 24 months
Key Outcome Measures Prostate symptoms (for BPH), cocaine use reduction, sleep quality, nightmare frequency, smoking behavior
Common Side Effects Monitored Changes in blood pressure, dizziness, sexual function alterations
Unique Applications Sleep improvement in PTSD, stress-induced smoking reduction

Ongoing Clinical Trials on Doxazosin Mesilate

  • Evaluation of clonidine and doxazosin for treating nightmares in adults with Post-traumatic Stress Disorder

    Not recruiting

    1 1
    Investigated diseases:
    Germany

Glossary

  • Benign Prostatic Hyperplasia (BPH): A non-cancerous enlargement of the prostate gland that can cause urinary symptoms in older men.
  • Alpha-1 adrenergic receptor: A type of receptor in the body that, when blocked by medications like Doxazosin, can help relax smooth muscles in blood vessels and the prostate.
  • Doxazosin Mesilate: A medication belonging to the class of alpha-1 adrenergic blockers, used to treat high blood pressure and symptoms of BPH.
  • Post-Traumatic Stress Disorder (PTSD): A mental health condition triggered by experiencing or witnessing a terrifying event, often characterized by nightmares, flashbacks, and severe anxiety.
  • Cocaine Dependence: A psychological and physical addiction to cocaine, a powerful stimulant drug.
  • Polysomnography: A comprehensive sleep study that records brain waves, blood oxygen levels, heart rate, breathing, and eye and leg movements during sleep.
  • Actigraphy: A non-invasive method of monitoring human rest/activity cycles, typically using a wrist-worn device.
  • Wake After Sleep Onset (WASO): A measure of sleep quality that represents the amount of time spent awake after initially falling asleep.
  • Total Sleep Time (TST): The total amount of time spent asleep during a sleep period.
  • REM Sleep: Rapid Eye Movement sleep, a stage of sleep associated with dreaming and important for memory consolidation and cognitive function.

References

  1. https://clinicaltrials.gov/study/NCT01003886
  2. https://clinicaltrials.gov/study/NCT01953432
  3. https://clinicaltrials.gov/study/NCT03339258
  4. https://clinicaltrials.gov/study/NCT02308202
  5. https://clinicaltrials.gov/study/NCT00880997
  6. https://clinicaltrials.gov/study/NCT01145183
  7. https://clinicaltrials.gov/study/NCT01959022
  8. https://clinicaltrials.gov/study/NCT01730846